The Gerontological Society of America

  • Online Store
  • Site Map
  • Press Room
  • Decrease font size
  • Default font size
  • Increase font size
  • RSS Feed

Member Log-in

Forgot your username?

Password is case sensitive
Forgot your password?

Not a Member?   Join Now!

Home About Us National Adult Vaccination Program
National Adult Vaccination Program

NAVP LogoThe National Adult Vaccination Program (NAVP), is a multi-stakeholder industry-supported collaboration to develop a cohesive strategic and policy approach to improve adult vaccination aligned with the recommendations of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention.  The Patient Protection and Affordable Care Act of 2010 included several provisions that emphasize the value of preventive services for older adults, including immunizations. NAVP, to the extent possible, will focus on achieving the Healthy People 2020 immunization goals and such areas as already identified and accepted factors that drive high pediatric immunization rates and translate them to the adult population, adopting a clear adult immunization schedule and driving greater public, provider, and payer awareness of the health benefits of adult immunizations.

Visit the NAVP's new home at!

NAVP Workgroup
R. Gordon Douglas, MD
NAVP Workgroup Chairperson    
Weill Cornell Medical College

Paul Etkind, DrPH, MPH    
National Association of County and City Health Officials
Stefan Gravenstein, MD, MPH
NAVP Project Director     
Warren Alpert Medical School of Brown University
Healthcentric Advisors

Walter A. Orenstein, MD
Emory University School of Medicine
Emory Vaccine Center
Barbara Resnick, PhD, RN, CRNP    
University of Maryland School of Nursing and School of Medicine

William Schaffner, MD    
Vanderbilt University School of Medicine
The Edward Jenner Society
NAVP Resources

NAVP is developed by GSA and supported by GlaxoSmithKline, Merck, Novartis Vaccines, Pfizer, and Sanofi Pasteur.